Dee Sreerangaiah1, Michael Grayer2, Benjamin A Fisher1, Meilien Ho3, Sonya Abraham1, Peter C Taylor4. 1. Kennedy Institute of Rheumatology Division, Imperial College. 2. Dianthus Medical Ltd., London. 3. Global Medicines Development, AstraZeneca, Cheshire and. 4. Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford, Oxford, UK peter.taylor@kennedy.ox.ac.uk.
Abstract
OBJECTIVE: To assess the value of quantitative vascular imaging by power Doppler US (PDUS) as a tool that can be used to stratify patient risk of joint damage in early seropositive RA while still biologic naive but on synthetic DMARD treatment. METHODS: Eighty-five patients with seropositive RA of <3 years duration had clinical, laboratory and imaging assessments at 0 and 12 months. Imaging assessments consisted of radiographs of the hands and feet, two-dimensional (2D) high-frequency and PDUS imaging of 10 MCP joints that were scored for erosions and vascularity and three-dimensional (3D) PDUS of MCP joints and wrists that were scored for vascularity. RESULTS: Severe deterioration on radiographs and ultrasonography was seen in 45 and 28% of patients, respectively. The 3D power Doppler volume and 2D vascularity scores were the most useful US predictors of deterioration. These variables were modelled in two equations that estimate structural damage over 12 months. The equations had a sensitivity of 63.2% and specificity of 80.9% for predicting radiographic structural damage and a sensitivity of 54.2% and specificity of 96.7% for predicting structural damage on ultrasonography. CONCLUSION: In seropositive early RA, quantitative vascular imaging by PDUS has clinical utility in predicting which patients will derive benefit from early use of biologic therapy.
OBJECTIVE: To assess the value of quantitative vascular imaging by power Doppler US (PDUS) as a tool that can be used to stratify patient risk of joint damage in early seropositive RA while still biologic naive but on synthetic DMARD treatment. METHODS: Eighty-five patients with seropositive RA of <3 years duration had clinical, laboratory and imaging assessments at 0 and 12 months. Imaging assessments consisted of radiographs of the hands and feet, two-dimensional (2D) high-frequency and PDUS imaging of 10 MCP joints that were scored for erosions and vascularity and three-dimensional (3D) PDUS of MCP joints and wrists that were scored for vascularity. RESULTS: Severe deterioration on radiographs and ultrasonography was seen in 45 and 28% of patients, respectively. The 3D power Doppler volume and 2D vascularity scores were the most useful US predictors of deterioration. These variables were modelled in two equations that estimate structural damage over 12 months. The equations had a sensitivity of 63.2% and specificity of 80.9% for predicting radiographic structural damage and a sensitivity of 54.2% and specificity of 96.7% for predicting structural damage on ultrasonography. CONCLUSION: In seropositive early RA, quantitative vascular imaging by PDUS has clinical utility in predicting which patients will derive benefit from early use of biologic therapy.
Authors: Marcin Szkudlarek; Michel Court-Payen; Søren Jacobsen; Mette Klarlund; Henrik S Thomsen; Mikkel Østergaard Journal: Arthritis Rheum Date: 2003-04
Authors: R J Wakefield; W W Gibbon; P G Conaghan; P O'Connor; D McGonagle; C Pease; M J Green; D J Veale; J D Isaacs; P Emery Journal: Arthritis Rheum Date: 2000-12
Authors: A K Brown; M A Quinn; Z Karim; P G Conaghan; C G Peterfy; E Hensor; R J Wakefield; P J O'Connor; P Emery Journal: Arthritis Rheum Date: 2006-12
Authors: P C Taylor; A Steuer; J Gruber; C McClinton; D O Cosgrove; M J K Blomley; P A Marsters; C L Wagner; R N Maini Journal: Arthritis Rheum Date: 2006-01
Authors: Andrew Filer; Paola de Pablo; Gina Allen; Peter Nightingale; Alison Jordan; Paresh Jobanputra; Simon Bowman; Christopher D Buckley; Karim Raza Journal: Ann Rheum Dis Date: 2010-11-29 Impact factor: 19.103
Authors: Edward Keystone; Désireé van der Heijde; David Mason; Robert Landewé; Ronald Van Vollenhoven; Bernard Combe; Paul Emery; Vibeke Strand; Philip Mease; Chintu Desai; Karel Pavelka Journal: Arthritis Rheum Date: 2008-11
Authors: Carmen Gómez-Vaquero; Irene Martín; Estibaliz Loza; Loreto Carmona; José Ivorra; José Antonio Narváez; Javier Hernández-Gañán; Pedro Alía; Javier Narváez Journal: PLoS One Date: 2016-12-02 Impact factor: 3.240